Autologous haematopoietic stem cell transplant for patients with highly active relapsing remitting multiple sclerosis not responding to high-efficacy disease modifying therapies; in response to an enquiry from the Strategic Planning and Clinical Priorities Team, Planning and Quality Division, Scottish Government.
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
Includes bibliographical references.
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 27 November 2019)
Autotransplantation
Stem cells
Multiple sclerosis